Kynexis, a biotechnology company focused on precision therapeutics for brain diseases, launched today with €57 million in Series A financing led by Forbion, with participation from Ysios Capital and...
El CDTI Innovación, a través de su programa Innvierte, conjuntamente con Nuubo Investments FCRE, ha alcanzado un acuerdo con los socios de NUUBO para realizar una nueva aportación en el capital de ...
The corporate perimeter acquired by GED, with a turnover of approximately 100 million euros, includes more than 35 clinics, as well as the central services, located at the Barcelona headquarters, wher...
El evento contará con la participación de startups especializadas en biotecnología aplicada a la salud, la industria farmacéutica y tecnológica, así como inversores, emprendedores, investigadore...
Arcano ha asesorado a IVI RMA GLOBAL, participada de KKR, en la adquisición del negocio de Eugin Group en Estados Unidos y Canadá. Esta operación se ha realizado junto con GED Capital, que adquiere...
The Riverside Company has acquired Frenchies Modern Nail Care (Frenchies), a franchisor that provides nail care services. Based in Littleton, Colorado, the Frenchies franchise system provides full-ser...
HT Médica is Fremman’s sixth platform investment, having been signed just a few months after announcing the final closing of its debut fund, raising over €600 million, and its first platform exit...
La empresa de diagnóstico internacional Werfen progresa rápidamente con su rama especializada en capital riesgo, We Venture Capital. Recientemente, la empresa ha concretado dos nuevas transacciones,...
Grupo Elha cuenta con el mayor número de centros propios en España, con una red de 120 centros en más de 50 ciudades. Este año, inició su expansión internacional con la apertura de 4 nuevos cent...
The Riverside Company has invested in Executive Health Solutions (EHS). The company is an add-on investment to Riverside’s platform, Altius Group Holdings (Altius), a leading provider of occupationa...
Life Sciences I closed above its fundraising target, with $650 million in equity commitments from a global, diverse group of institutional, strategic and high net worth investors and meaningful commit...
Stubborn inflation, high interest rates, geopolitical and economic uncertainty, and labor shortages exacted a toll on private equity markets in 2023, and healthcare private equity was not immune. H...